For use in: horses
Utilizes the patient's own blood and natural healing mechanisms. The patented irap syringe produces autologous conditioned serum which contains active quantities of anti-inflammatory and regenerative cytokines.
60 mL irap syringe, 20G butterfly cannula, syringe cap.
Storage box included
Size: 60 mL
Package Insert: Download
GROUP1298
For use in: dogs and horses
Utilizes the patient's own blood and natural healing mechanisms. The patented irap syringe produces autologous conditioned serum which contains active quantities of anti-inflammatory and regenerative cytokines.
Three 10mL irap syringes, three vacutainer adapters, one 10mL balance syringe, three 0.2 micron filters, three spinal needles, three syringe caps.
Storage box included
Size: 3 x 10 mL
Package Insert: Download
GROUP1303
For use in: horses
OSPHOS is an injectable bisphosphonate solution for the control of clinical signs associated with navicular syndrome in horses four years and older.
Active(s): Clodronate disodium
Size: 15 mL
Package Insert: Download
GROUP1298
For use in: horses
A device used to accelerate the tissue healing process in horses by producing platelet-rich plasma.
Dual bag processing device, 20G butterfly cannula, syringes.
Active(s): Citrate sodium (anticoagulant)
Size: 1
Package Insert: Download
GROUP1298
OSPHOS
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. As with all drugs, side effects may occur. In field studies, the most common side effects reported were signs of discomfort or nervousness, colic, and/or pawing. OSPHOS should not be used in pregnant or lactating mares, or mares intended for breeding. Use of OSPHOS in patients with conditions affecting renal function or mineral or electrolyte homeostasis is not recommended. Refer to the prescribing information for complete details. OSPHOS Package Insert
Navigation